Spain Leads Europe in Multinational Clinical Trials with 770 Authorizations in 2024
Spain leads Europe in multinational clinical trial authorizations in 2024, with 770 approvals and a key role in the upcoming FAST-EU initiative.
Spain leads Europe in multinational clinical trial authorizations in 2024, with 770 approvals and a key role in the upcoming FAST-EU initiative.
Spain ranks low in type 1 diabetes clinical trials, with calls for national leadership and increased investment amid upcoming medical congress discussions.